Table 3.
of Post-operative Medication and Laboratory Examinations in All Patients
| Variablea | Group non-NC (n = 264) |
Group NC (n = 43) |
p-value (Non-NC vs NC) |
Group CVA (n = 35) |
p-value (Non-NC vs CVA) |
|---|---|---|---|---|---|
| Medication | |||||
| Warfarin | 195 (73.8) | 36 (83.7) | 0.165 | 29 (82.9) | 0.249 |
| Aspirin | 238 (90.1) | 38 (88.4) | 0.828 | 32 (91.4) | 0.721 |
| Laboratory examinations | |||||
| White cell count, ×103/µL | 7.9 ± 2.3 | 8.5 ± 3.4 | 0.142 | 8.2 ± 3.5 | 0.499 |
| Lymphocytes, % | 13.0 ± 6.2 | 12.1 ± 4.9 | 0.365 | 12.3 ± 4.6 | 0.520 |
| Hematocrit, % | 37.8 ± 6.1 | 34.9 ± 5.1 | 0.003 | 34.7 ± 6.3 | 0.005 |
| Platelets, ×103/µl | 189 ± 90 | 201 ± 82 | 0.402 | 199 ± 85 | 0.54 |
| Bilirubin, mg/dl | |||||
| Total | 1.6 ± 2.9 | 1.9 ± 3.1 | 0.534 | 1.7 ± 2.6 | 0.846 |
| Direct | 0.8 ± 2.2 | 1.0 ± 1.8 | 0.572 | 0.8 ± 0.9 | 0.937 |
| Sodium, mEq/L | 134.4 ± 6.4 | 131.6 ± 7.7 | 0.010 | 131.9 ± 7.1 | 0.033 |
| Potassium, mEq/L | 4.3 ± 0.6 | 4.4 ± 0.4 | 0.292 | 4.3 ± 0.4 | 0.848 |
| Blood urea nitrogen, mg/dl | 33 ± 14 | 32 ± 18 | 0.866 | 33 ± 17 | 0.755 |
| Creatinine, mg/dl | 1.5 ± 0.6 | 1.5 ± 0.7 | 0.623 | 1.4 ± 0.7 | 0.717 |
| Albumin, mg/dl | 3.9 ± 0.5 | 3.7 ± 0.5 | 0.016 | 3.7 ± 0.7 | 0.036 |
| ALT, IU/liter | 67 ± 99 | 66 ± 38 | 0.921 | 61 ± 51 | 0.716 |
| AST, IU/liter | 79 ± 86 | 58 ± 80 | 0.140 | 60 ± 77 | 0.222 |
| BNP, pg/ml | 802 ± 894 | 673 ± 685 | 0.571 | 712 ± 746 | 0.663 |
| International normalized ratio | 1.5 ± 0.9 | 1.6 ± 0.7 | 0.532 | 1.5 ± 0.3 | 0.845 |
ALT, Alanine aminotransferase; AST, aspartate aminotransferase; BNP, brain natriuretic peptide; CVA, cerebrovascular accident; NC, neurologic complication.
a
Categoric data are presented as number (%), and continuous data as mean ± standard deviation.